Patients diagnosed with acquired (autoimmune) hemophilia, a serious and rare bleeding disorder, have high rates of hospital ...

Genentech’s short film draws on the experiences of multiple families caring for children with hemophilia A, seeking to ...

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to ...

The Hemophilia B treatment landscape is entering a new era, marked by disruptive innovation, curative potential, and renewed global attention. Once viewed as a lifelong burden requiring constant ...

VIJAYAWADA: The State government is committed to ensuring uninterrupted care for citizens with rare and chronic disorders ...

What might cause minimal bleeding in someone without the condition can become a serious health concern requiring immediate intervention for someone with this disorder. Hemophilia A manifests ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

Discover 8 key causes of bloody cough from infections to lung conditions. Learn when coughing blood needs medical attention ...

Bayer’s Jivi is a factor VIII replacement therapy that has been engineered with a compound that allows for less frequent dosing. It is now indicated for patients 7 years of age and older.

Minister emphasizes raising awareness about genetic disorders like thalassemia, sickle cell anemia, and hemophilia for timely ...

Treatment options for children with hemophilia A have expanded with the FDA approval of Bayer's Jivi antihemophilic factor (recombinant), PEGylated-aucl for the treatment of pediatric patients between ...

Although less common than hemophilia or von Willebrand disease, inherited rare bleeding disorders, comprising afibrinogenemia and deficiencies in factors II, V, VII, X, XI, XIII or V plus VIII ...